nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—CYP3A4—Estropipate—osteoporosis	0.0703	0.158	CbGbCtD
Rivastigmine—CYP3A4—Calcitriol—osteoporosis	0.0703	0.158	CbGbCtD
Rivastigmine—CYP2D6—Cholecalciferol—osteoporosis	0.0569	0.128	CbGbCtD
Rivastigmine—CYP3A4—Ergocalciferol—osteoporosis	0.0562	0.126	CbGbCtD
Rivastigmine—CYP3A4—Raloxifene—osteoporosis	0.0469	0.105	CbGbCtD
Rivastigmine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0453	0.102	CbGbCtD
Rivastigmine—CYP3A4—Cholecalciferol—osteoporosis	0.0362	0.0814	CbGbCtD
Rivastigmine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0332	0.0748	CbGbCtD
Rivastigmine—CYP3A4—Estradiol—osteoporosis	0.0292	0.0656	CbGbCtD
Rivastigmine—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000513	0.0684	CbGpPWpGaD
Rivastigmine—ACHE—Monoamine Transport—TNFRSF11B—osteoporosis	0.000323	0.0431	CbGpPWpGaD
Rivastigmine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—osteoporosis	0.000245	0.0326	CbGpPWpGaD
Rivastigmine—ACHE—Glycerophospholipid biosynthesis—MGLL—osteoporosis	0.000223	0.0298	CbGpPWpGaD
Rivastigmine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—osteoporosis	0.000218	0.0291	CbGpPWpGaD
Rivastigmine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—osteoporosis	0.000202	0.0269	CbGpPWpGaD
Rivastigmine—BCHE—Glycerophospholipid biosynthesis—MGLL—osteoporosis	0.000199	0.0266	CbGpPWpGaD
Rivastigmine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—osteoporosis	0.00018	0.024	CbGpPWpGaD
Rivastigmine—Hypotension—Pamidronate—osteoporosis	0.000178	0.000324	CcSEcCtD
Rivastigmine—Convulsion—Conjugated Estrogens—osteoporosis	0.000177	0.000324	CcSEcCtD
Rivastigmine—Dry mouth—Zoledronate—osteoporosis	0.000177	0.000323	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000177	0.000323	CcSEcCtD
Rivastigmine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000177	0.000323	CcSEcCtD
Rivastigmine—Pruritus—Alendronate—osteoporosis	0.000176	0.000322	CcSEcCtD
Rivastigmine—Dyspepsia—Risedronate—osteoporosis	0.000176	0.000321	CcSEcCtD
Rivastigmine—Eye disorder—Estradiol—osteoporosis	0.000176	0.000321	CcSEcCtD
Rivastigmine—Tinnitus—Estradiol—osteoporosis	0.000176	0.00032	CcSEcCtD
Rivastigmine—Constipation—Ethinyl Estradiol—osteoporosis	0.000175	0.00032	CcSEcCtD
Rivastigmine—Confusional state—Zoledronate—osteoporosis	0.000175	0.000319	CcSEcCtD
Rivastigmine—Hypersensitivity—Calcitriol—osteoporosis	0.000175	0.000319	CcSEcCtD
Rivastigmine—Flushing—Estradiol—osteoporosis	0.000175	0.000319	CcSEcCtD
Rivastigmine—Cardiac disorder—Estradiol—osteoporosis	0.000175	0.000319	CcSEcCtD
Rivastigmine—Chest pain—Conjugated Estrogens—osteoporosis	0.000174	0.000318	CcSEcCtD
Rivastigmine—Myalgia—Conjugated Estrogens—osteoporosis	0.000174	0.000318	CcSEcCtD
Rivastigmine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000174	0.000318	CcSEcCtD
Rivastigmine—ACHE—Peptide hormone metabolism—REN—osteoporosis	0.000174	0.0232	CbGpPWpGaD
Rivastigmine—Asthenia—Ibandronate—osteoporosis	0.000174	0.000318	CcSEcCtD
Rivastigmine—Anxiety—Conjugated Estrogens—osteoporosis	0.000174	0.000317	CcSEcCtD
Rivastigmine—Nausea—Etidronic acid—osteoporosis	0.000174	0.000317	CcSEcCtD
Rivastigmine—Oedema—Zoledronate—osteoporosis	0.000174	0.000317	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000173	0.000316	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000173	0.000316	CcSEcCtD
Rivastigmine—Diarrhoea—Estropipate—osteoporosis	0.000173	0.000316	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000173	0.000315	CcSEcCtD
Rivastigmine—Infection—Zoledronate—osteoporosis	0.000172	0.000315	CcSEcCtD
Rivastigmine—Fatigue—Risedronate—osteoporosis	0.000172	0.000314	CcSEcCtD
Rivastigmine—Insomnia—Pamidronate—osteoporosis	0.000172	0.000314	CcSEcCtD
Rivastigmine—Pruritus—Ibandronate—osteoporosis	0.000172	0.000313	CcSEcCtD
Rivastigmine—Pain—Risedronate—osteoporosis	0.000171	0.000312	CcSEcCtD
Rivastigmine—Constipation—Risedronate—osteoporosis	0.000171	0.000312	CcSEcCtD
Rivastigmine—Angiopathy—Estradiol—osteoporosis	0.000171	0.000312	CcSEcCtD
Rivastigmine—Shock—Zoledronate—osteoporosis	0.000171	0.000312	CcSEcCtD
Rivastigmine—Paraesthesia—Pamidronate—osteoporosis	0.000171	0.000311	CcSEcCtD
Rivastigmine—Diarrhoea—Alendronate—osteoporosis	0.00017	0.000311	CcSEcCtD
Rivastigmine—Asthenia—Calcitriol—osteoporosis	0.00017	0.000311	CcSEcCtD
Rivastigmine—Nervous system disorder—Zoledronate—osteoporosis	0.00017	0.000311	CcSEcCtD
Rivastigmine—Thrombocytopenia—Zoledronate—osteoporosis	0.00017	0.00031	CcSEcCtD
Rivastigmine—Mediastinal disorder—Estradiol—osteoporosis	0.00017	0.00031	CcSEcCtD
Rivastigmine—Dyspnoea—Pamidronate—osteoporosis	0.000169	0.000309	CcSEcCtD
Rivastigmine—Tachycardia—Zoledronate—osteoporosis	0.000169	0.000309	CcSEcCtD
Rivastigmine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000169	0.000308	CcSEcCtD
Rivastigmine—Chills—Estradiol—osteoporosis	0.000169	0.000308	CcSEcCtD
Rivastigmine—Somnolence—Pamidronate—osteoporosis	0.000169	0.000308	CcSEcCtD
Rivastigmine—Skin disorder—Zoledronate—osteoporosis	0.000169	0.000308	CcSEcCtD
Rivastigmine—Pruritus—Calcitriol—osteoporosis	0.000168	0.000307	CcSEcCtD
Rivastigmine—Hyperhidrosis—Zoledronate—osteoporosis	0.000168	0.000306	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000168	0.000306	CcSEcCtD
Rivastigmine—Diarrhoea—Raloxifene—osteoporosis	0.000168	0.000306	CcSEcCtD
Rivastigmine—Dyspepsia—Pamidronate—osteoporosis	0.000167	0.000305	CcSEcCtD
Rivastigmine—Dizziness—Estropipate—osteoporosis	0.000167	0.000305	CcSEcCtD
Rivastigmine—Oedema—Conjugated Estrogens—osteoporosis	0.000167	0.000305	CcSEcCtD
Rivastigmine—Alopecia—Estradiol—osteoporosis	0.000166	0.000304	CcSEcCtD
Rivastigmine—Infection—Conjugated Estrogens—osteoporosis	0.000166	0.000303	CcSEcCtD
Rivastigmine—Diarrhoea—Ibandronate—osteoporosis	0.000166	0.000303	CcSEcCtD
Rivastigmine—Anorexia—Zoledronate—osteoporosis	0.000165	0.000302	CcSEcCtD
Rivastigmine—Decreased appetite—Pamidronate—osteoporosis	0.000165	0.000301	CcSEcCtD
Rivastigmine—Mental disorder—Estradiol—osteoporosis	0.000165	0.000301	CcSEcCtD
Rivastigmine—Dizziness—Alendronate—osteoporosis	0.000165	0.000301	CcSEcCtD
Rivastigmine—Shock—Conjugated Estrogens—osteoporosis	0.000164	0.0003	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000164	0.000299	CcSEcCtD
Rivastigmine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000164	0.000299	CcSEcCtD
Rivastigmine—Erythema—Estradiol—osteoporosis	0.000164	0.000299	CcSEcCtD
Rivastigmine—Malnutrition—Estradiol—osteoporosis	0.000164	0.000299	CcSEcCtD
Rivastigmine—Fatigue—Pamidronate—osteoporosis	0.000164	0.000299	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Risedronate—osteoporosis	0.000163	0.000298	CcSEcCtD
Rivastigmine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000163	0.000298	CcSEcCtD
Rivastigmine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000163	0.000297	CcSEcCtD
Rivastigmine—Pain—Pamidronate—osteoporosis	0.000162	0.000297	CcSEcCtD
Rivastigmine—Constipation—Pamidronate—osteoporosis	0.000162	0.000297	CcSEcCtD
Rivastigmine—Diarrhoea—Calcitriol—osteoporosis	0.000162	0.000296	CcSEcCtD
Rivastigmine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000162	0.000296	CcSEcCtD
Rivastigmine—Hypotension—Zoledronate—osteoporosis	0.000162	0.000296	CcSEcCtD
Rivastigmine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000162	0.000296	CcSEcCtD
Rivastigmine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000162	0.000296	CcSEcCtD
Rivastigmine—Dizziness—Raloxifene—osteoporosis	0.000162	0.000296	CcSEcCtD
Rivastigmine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000162	0.000295	CcSEcCtD
Rivastigmine—Flatulence—Estradiol—osteoporosis	0.000161	0.000295	CcSEcCtD
Rivastigmine—Tension—Estradiol—osteoporosis	0.000161	0.000293	CcSEcCtD
Rivastigmine—Vomiting—Estropipate—osteoporosis	0.000161	0.000293	CcSEcCtD
Rivastigmine—Dysgeusia—Estradiol—osteoporosis	0.00016	0.000293	CcSEcCtD
Rivastigmine—Dizziness—Ibandronate—osteoporosis	0.00016	0.000293	CcSEcCtD
Rivastigmine—Rash—Estropipate—osteoporosis	0.000159	0.000291	CcSEcCtD
Rivastigmine—Dermatitis—Estropipate—osteoporosis	0.000159	0.000291	CcSEcCtD
Rivastigmine—Anorexia—Conjugated Estrogens—osteoporosis	0.000159	0.000291	CcSEcCtD
Rivastigmine—Nervousness—Estradiol—osteoporosis	0.000159	0.00029	CcSEcCtD
Rivastigmine—Urticaria—Risedronate—osteoporosis	0.000159	0.00029	CcSEcCtD
Rivastigmine—Back pain—Estradiol—osteoporosis	0.000159	0.000289	CcSEcCtD
Rivastigmine—Headache—Estropipate—osteoporosis	0.000158	0.000289	CcSEcCtD
Rivastigmine—Vomiting—Alendronate—osteoporosis	0.000158	0.000289	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000158	0.000289	CcSEcCtD
Rivastigmine—Abdominal pain—Risedronate—osteoporosis	0.000158	0.000288	CcSEcCtD
Rivastigmine—Body temperature increased—Risedronate—osteoporosis	0.000158	0.000288	CcSEcCtD
Rivastigmine—Muscle spasms—Estradiol—osteoporosis	0.000158	0.000288	CcSEcCtD
Rivastigmine—Rash—Alendronate—osteoporosis	0.000157	0.000287	CcSEcCtD
Rivastigmine—Insomnia—Zoledronate—osteoporosis	0.000157	0.000286	CcSEcCtD
Rivastigmine—Dermatitis—Alendronate—osteoporosis	0.000157	0.000286	CcSEcCtD
Rivastigmine—Feeling abnormal—Pamidronate—osteoporosis	0.000157	0.000286	CcSEcCtD
Rivastigmine—Hypotension—Conjugated Estrogens—osteoporosis	0.000156	0.000285	CcSEcCtD
Rivastigmine—Headache—Alendronate—osteoporosis	0.000156	0.000285	CcSEcCtD
Rivastigmine—ACHE—Phospholipid metabolism—MGLL—osteoporosis	0.000156	0.0208	CbGpPWpGaD
Rivastigmine—Paraesthesia—Zoledronate—osteoporosis	0.000156	0.000284	CcSEcCtD
Rivastigmine—Vomiting—Raloxifene—osteoporosis	0.000156	0.000284	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000155	0.000284	CcSEcCtD
Rivastigmine—BCHE—Peptide hormone metabolism—REN—osteoporosis	0.000155	0.0207	CbGpPWpGaD
Rivastigmine—Dyspnoea—Zoledronate—osteoporosis	0.000155	0.000282	CcSEcCtD
Rivastigmine—Rash—Raloxifene—osteoporosis	0.000154	0.000282	CcSEcCtD
Rivastigmine—Dermatitis—Raloxifene—osteoporosis	0.000154	0.000282	CcSEcCtD
Rivastigmine—Somnolence—Zoledronate—osteoporosis	0.000154	0.000282	CcSEcCtD
Rivastigmine—Vomiting—Ibandronate—osteoporosis	0.000154	0.000281	CcSEcCtD
Rivastigmine—Tremor—Estradiol—osteoporosis	0.000154	0.00028	CcSEcCtD
Rivastigmine—Headache—Raloxifene—osteoporosis	0.000153	0.00028	CcSEcCtD
Rivastigmine—Rash—Ibandronate—osteoporosis	0.000153	0.000279	CcSEcCtD
Rivastigmine—Dermatitis—Ibandronate—osteoporosis	0.000153	0.000279	CcSEcCtD
Rivastigmine—Dyspepsia—Zoledronate—osteoporosis	0.000153	0.000279	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000152	0.000278	CcSEcCtD
Rivastigmine—Ill-defined disorder—Estradiol—osteoporosis	0.000152	0.000278	CcSEcCtD
Rivastigmine—Headache—Ibandronate—osteoporosis	0.000152	0.000277	CcSEcCtD
Rivastigmine—Insomnia—Conjugated Estrogens—osteoporosis	0.000151	0.000276	CcSEcCtD
Rivastigmine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000151	0.000276	CcSEcCtD
Rivastigmine—Vomiting—Calcitriol—osteoporosis	0.000151	0.000275	CcSEcCtD
Rivastigmine—Decreased appetite—Zoledronate—osteoporosis	0.000151	0.000275	CcSEcCtD
Rivastigmine—Agitation—Estradiol—osteoporosis	0.000151	0.000275	CcSEcCtD
Rivastigmine—Nausea—Estropipate—osteoporosis	0.00015	0.000274	CcSEcCtD
Rivastigmine—Body temperature increased—Pamidronate—osteoporosis	0.00015	0.000274	CcSEcCtD
Rivastigmine—Abdominal pain—Pamidronate—osteoporosis	0.00015	0.000274	CcSEcCtD
Rivastigmine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00015	0.000274	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00015	0.000273	CcSEcCtD
Rivastigmine—Rash—Calcitriol—osteoporosis	0.00015	0.000273	CcSEcCtD
Rivastigmine—Fatigue—Zoledronate—osteoporosis	0.00015	0.000273	CcSEcCtD
Rivastigmine—Dermatitis—Calcitriol—osteoporosis	0.00015	0.000273	CcSEcCtD
Rivastigmine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000149	0.000272	CcSEcCtD
Rivastigmine—Headache—Calcitriol—osteoporosis	0.000149	0.000271	CcSEcCtD
Rivastigmine—Somnolence—Conjugated Estrogens—osteoporosis	0.000149	0.000271	CcSEcCtD
Rivastigmine—Constipation—Zoledronate—osteoporosis	0.000148	0.000271	CcSEcCtD
Rivastigmine—Pain—Zoledronate—osteoporosis	0.000148	0.000271	CcSEcCtD
Rivastigmine—Nausea—Alendronate—osteoporosis	0.000148	0.00027	CcSEcCtD
Rivastigmine—Malaise—Estradiol—osteoporosis	0.000148	0.00027	CcSEcCtD
Rivastigmine—Hypersensitivity—Risedronate—osteoporosis	0.000147	0.000269	CcSEcCtD
Rivastigmine—Vertigo—Estradiol—osteoporosis	0.000147	0.000269	CcSEcCtD
Rivastigmine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000147	0.000268	CcSEcCtD
Rivastigmine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000147	0.000268	CcSEcCtD
Rivastigmine—Syncope—Estradiol—osteoporosis	0.000147	0.000268	CcSEcCtD
Rivastigmine—Nausea—Raloxifene—osteoporosis	0.000146	0.000266	CcSEcCtD
Rivastigmine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000145	0.000265	CcSEcCtD
Rivastigmine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000145	0.000265	CcSEcCtD
Rivastigmine—Palpitations—Estradiol—osteoporosis	0.000145	0.000264	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000144	0.000263	CcSEcCtD
Rivastigmine—Fatigue—Conjugated Estrogens—osteoporosis	0.000144	0.000263	CcSEcCtD
Rivastigmine—Nausea—Ibandronate—osteoporosis	0.000144	0.000263	CcSEcCtD
Rivastigmine—Loss of consciousness—Estradiol—osteoporosis	0.000144	0.000263	CcSEcCtD
Rivastigmine—Asthenia—Risedronate—osteoporosis	0.000143	0.000262	CcSEcCtD
Rivastigmine—Feeling abnormal—Zoledronate—osteoporosis	0.000143	0.000261	CcSEcCtD
Rivastigmine—Cough—Estradiol—osteoporosis	0.000143	0.000261	CcSEcCtD
Rivastigmine—Pain—Conjugated Estrogens—osteoporosis	0.000143	0.000261	CcSEcCtD
Rivastigmine—Constipation—Conjugated Estrogens—osteoporosis	0.000143	0.000261	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000142	0.000259	CcSEcCtD
Rivastigmine—Hypertension—Estradiol—osteoporosis	0.000141	0.000258	CcSEcCtD
Rivastigmine—Pruritus—Risedronate—osteoporosis	0.000141	0.000258	CcSEcCtD
Rivastigmine—Nausea—Calcitriol—osteoporosis	0.000141	0.000257	CcSEcCtD
Rivastigmine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00014	0.000256	CcSEcCtD
Rivastigmine—Hypersensitivity—Pamidronate—osteoporosis	0.00014	0.000255	CcSEcCtD
Rivastigmine—Arthralgia—Estradiol—osteoporosis	0.00014	0.000255	CcSEcCtD
Rivastigmine—Chest pain—Estradiol—osteoporosis	0.00014	0.000255	CcSEcCtD
Rivastigmine—Myalgia—Estradiol—osteoporosis	0.00014	0.000255	CcSEcCtD
Rivastigmine—BCHE—Phospholipid metabolism—MGLL—osteoporosis	0.000139	0.0185	CbGpPWpGaD
Rivastigmine—Anxiety—Estradiol—osteoporosis	0.000139	0.000254	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000139	0.000253	CcSEcCtD
Rivastigmine—Urticaria—Zoledronate—osteoporosis	0.000138	0.000252	CcSEcCtD
Rivastigmine—Discomfort—Estradiol—osteoporosis	0.000138	0.000252	CcSEcCtD
Rivastigmine—Body temperature increased—Zoledronate—osteoporosis	0.000137	0.00025	CcSEcCtD
Rivastigmine—Abdominal pain—Zoledronate—osteoporosis	0.000137	0.00025	CcSEcCtD
Rivastigmine—Diarrhoea—Risedronate—osteoporosis	0.000137	0.00025	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000137	0.000249	CcSEcCtD
Rivastigmine—Dry mouth—Estradiol—osteoporosis	0.000136	0.000249	CcSEcCtD
Rivastigmine—Asthenia—Pamidronate—osteoporosis	0.000136	0.000249	CcSEcCtD
Rivastigmine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000136	0.000247	CcSEcCtD
Rivastigmine—Confusional state—Estradiol—osteoporosis	0.000135	0.000246	CcSEcCtD
Rivastigmine—Pruritus—Pamidronate—osteoporosis	0.000134	0.000245	CcSEcCtD
Rivastigmine—Oedema—Estradiol—osteoporosis	0.000134	0.000244	CcSEcCtD
Rivastigmine—Infection—Estradiol—osteoporosis	0.000133	0.000243	CcSEcCtD
Rivastigmine—Urticaria—Conjugated Estrogens—osteoporosis	0.000133	0.000242	CcSEcCtD
Rivastigmine—Dizziness—Risedronate—osteoporosis	0.000132	0.000241	CcSEcCtD
Rivastigmine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000132	0.000241	CcSEcCtD
Rivastigmine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000132	0.000241	CcSEcCtD
Rivastigmine—Shock—Estradiol—osteoporosis	0.000132	0.00024	CcSEcCtD
Rivastigmine—Nervous system disorder—Estradiol—osteoporosis	0.000131	0.000239	CcSEcCtD
Rivastigmine—Tachycardia—Estradiol—osteoporosis	0.000131	0.000238	CcSEcCtD
Rivastigmine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00013	0.000238	CcSEcCtD
Rivastigmine—Diarrhoea—Pamidronate—osteoporosis	0.00013	0.000237	CcSEcCtD
Rivastigmine—Skin disorder—Estradiol—osteoporosis	0.00013	0.000237	CcSEcCtD
Rivastigmine—Hyperhidrosis—Estradiol—osteoporosis	0.000129	0.000236	CcSEcCtD
Rivastigmine—Rash—Ethinyl Estradiol—osteoporosis	0.000129	0.000236	CcSEcCtD
Rivastigmine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000129	0.000236	CcSEcCtD
Rivastigmine—Headache—Ethinyl Estradiol—osteoporosis	0.000128	0.000234	CcSEcCtD
Rivastigmine—Hypersensitivity—Zoledronate—osteoporosis	0.000128	0.000233	CcSEcCtD
Rivastigmine—Vomiting—Risedronate—osteoporosis	0.000127	0.000232	CcSEcCtD
Rivastigmine—Rash—Risedronate—osteoporosis	0.000126	0.00023	CcSEcCtD
Rivastigmine—Dermatitis—Risedronate—osteoporosis	0.000126	0.00023	CcSEcCtD
Rivastigmine—Dizziness—Pamidronate—osteoporosis	0.000126	0.000229	CcSEcCtD
Rivastigmine—Headache—Risedronate—osteoporosis	0.000125	0.000229	CcSEcCtD
Rivastigmine—Asthenia—Zoledronate—osteoporosis	0.000125	0.000227	CcSEcCtD
Rivastigmine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000123	0.000225	CcSEcCtD
Rivastigmine—Pruritus—Zoledronate—osteoporosis	0.000123	0.000224	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000122	0.000222	CcSEcCtD
Rivastigmine—Nausea—Ethinyl Estradiol—osteoporosis	0.000122	0.000222	CcSEcCtD
Rivastigmine—Insomnia—Estradiol—osteoporosis	0.000121	0.000221	CcSEcCtD
Rivastigmine—Vomiting—Pamidronate—osteoporosis	0.000121	0.00022	CcSEcCtD
Rivastigmine—Paraesthesia—Estradiol—osteoporosis	0.00012	0.000219	CcSEcCtD
Rivastigmine—Asthenia—Conjugated Estrogens—osteoporosis	0.00012	0.000219	CcSEcCtD
Rivastigmine—Rash—Pamidronate—osteoporosis	0.00012	0.000219	CcSEcCtD
Rivastigmine—Dermatitis—Pamidronate—osteoporosis	0.00012	0.000218	CcSEcCtD
Rivastigmine—Dyspnoea—Estradiol—osteoporosis	0.000119	0.000218	CcSEcCtD
Rivastigmine—Headache—Pamidronate—osteoporosis	0.000119	0.000217	CcSEcCtD
Rivastigmine—Somnolence—Estradiol—osteoporosis	0.000119	0.000217	CcSEcCtD
Rivastigmine—Diarrhoea—Zoledronate—osteoporosis	0.000119	0.000217	CcSEcCtD
Rivastigmine—Nausea—Risedronate—osteoporosis	0.000119	0.000217	CcSEcCtD
Rivastigmine—Pruritus—Conjugated Estrogens—osteoporosis	0.000118	0.000216	CcSEcCtD
Rivastigmine—Dyspepsia—Estradiol—osteoporosis	0.000118	0.000215	CcSEcCtD
Rivastigmine—Decreased appetite—Estradiol—osteoporosis	0.000116	0.000212	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000115	0.000211	CcSEcCtD
Rivastigmine—Fatigue—Estradiol—osteoporosis	0.000115	0.00021	CcSEcCtD
Rivastigmine—Dizziness—Zoledronate—osteoporosis	0.000115	0.000209	CcSEcCtD
Rivastigmine—Constipation—Estradiol—osteoporosis	0.000114	0.000209	CcSEcCtD
Rivastigmine—Pain—Estradiol—osteoporosis	0.000114	0.000209	CcSEcCtD
Rivastigmine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000114	0.000209	CcSEcCtD
Rivastigmine—Nausea—Pamidronate—osteoporosis	0.000113	0.000206	CcSEcCtD
Rivastigmine—Dizziness—Conjugated Estrogens—osteoporosis	0.000111	0.000202	CcSEcCtD
Rivastigmine—Vomiting—Zoledronate—osteoporosis	0.00011	0.000201	CcSEcCtD
Rivastigmine—Feeling abnormal—Estradiol—osteoporosis	0.00011	0.000201	CcSEcCtD
Rivastigmine—Rash—Zoledronate—osteoporosis	0.000109	0.0002	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Estradiol—osteoporosis	0.000109	0.0002	CcSEcCtD
Rivastigmine—Dermatitis—Zoledronate—osteoporosis	0.000109	0.0002	CcSEcCtD
Rivastigmine—Headache—Zoledronate—osteoporosis	0.000109	0.000198	CcSEcCtD
Rivastigmine—ACHE—Peptide hormone metabolism—ACE—osteoporosis	0.000109	0.0145	CbGpPWpGaD
Rivastigmine—Vomiting—Conjugated Estrogens—osteoporosis	0.000106	0.000194	CcSEcCtD
Rivastigmine—Urticaria—Estradiol—osteoporosis	0.000106	0.000194	CcSEcCtD
Rivastigmine—Body temperature increased—Estradiol—osteoporosis	0.000106	0.000193	CcSEcCtD
Rivastigmine—Abdominal pain—Estradiol—osteoporosis	0.000106	0.000193	CcSEcCtD
Rivastigmine—Rash—Conjugated Estrogens—osteoporosis	0.000105	0.000192	CcSEcCtD
Rivastigmine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000105	0.000192	CcSEcCtD
Rivastigmine—Headache—Conjugated Estrogens—osteoporosis	0.000105	0.000191	CcSEcCtD
Rivastigmine—Nausea—Zoledronate—osteoporosis	0.000103	0.000188	CcSEcCtD
Rivastigmine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	9.95e-05	0.0133	CbGpPWpGaD
Rivastigmine—Nausea—Conjugated Estrogens—osteoporosis	9.93e-05	0.000181	CcSEcCtD
Rivastigmine—Hypersensitivity—Estradiol—osteoporosis	9.85e-05	0.00018	CcSEcCtD
Rivastigmine—CYP2D6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	9.82e-05	0.0131	CbGpPWpGaD
Rivastigmine—BCHE—Peptide hormone metabolism—ACE—osteoporosis	9.69e-05	0.0129	CbGpPWpGaD
Rivastigmine—Asthenia—Estradiol—osteoporosis	9.6e-05	0.000175	CcSEcCtD
Rivastigmine—Pruritus—Estradiol—osteoporosis	9.46e-05	0.000173	CcSEcCtD
Rivastigmine—ACHE—Monoamine Transport—IL1B—osteoporosis	9.4e-05	0.0125	CbGpPWpGaD
Rivastigmine—Diarrhoea—Estradiol—osteoporosis	9.15e-05	0.000167	CcSEcCtD
Rivastigmine—Dizziness—Estradiol—osteoporosis	8.85e-05	0.000161	CcSEcCtD
Rivastigmine—ACHE—ATF-2 transcription factor network—ESR1—osteoporosis	8.63e-05	0.0115	CbGpPWpGaD
Rivastigmine—Vomiting—Estradiol—osteoporosis	8.5e-05	0.000155	CcSEcCtD
Rivastigmine—Rash—Estradiol—osteoporosis	8.43e-05	0.000154	CcSEcCtD
Rivastigmine—Dermatitis—Estradiol—osteoporosis	8.43e-05	0.000154	CcSEcCtD
Rivastigmine—Headache—Estradiol—osteoporosis	8.38e-05	0.000153	CcSEcCtD
Rivastigmine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	8.19e-05	0.0109	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	8.07e-05	0.0108	CbGpPWpGaD
Rivastigmine—Nausea—Estradiol—osteoporosis	7.95e-05	0.000145	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	7.81e-05	0.0104	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	6.99e-05	0.00931	CbGpPWpGaD
Rivastigmine—ACHE—Monoamine Transport—TNF—osteoporosis	6.82e-05	0.00909	CbGpPWpGaD
Rivastigmine—ACHE—Peptide hormone metabolism—LEP—osteoporosis	6.75e-05	0.00899	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	6.62e-05	0.00883	CbGpPWpGaD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	6.51e-05	0.00867	CbGpPWpGaD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	6.42e-05	0.00856	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	6.23e-05	0.00831	CbGpPWpGaD
Rivastigmine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	6.13e-05	0.00817	CbGpPWpGaD
Rivastigmine—BCHE—Peptide hormone metabolism—LEP—osteoporosis	6.02e-05	0.00802	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	5.91e-05	0.00787	CbGpPWpGaD
Rivastigmine—ACHE—Peptide hormone metabolism—POMC—osteoporosis	5.8e-05	0.00773	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—CCT2—osteoporosis	5.72e-05	0.00763	CbGpPWpGaD
Rivastigmine—ACHE—Peptide hormone metabolism—IGF1—osteoporosis	5.58e-05	0.00743	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	5.56e-05	0.00741	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	5.27e-05	0.00703	CbGpPWpGaD
Rivastigmine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	5.23e-05	0.00697	CbGpPWpGaD
Rivastigmine—BCHE—Peptide hormone metabolism—POMC—osteoporosis	5.17e-05	0.00689	CbGpPWpGaD
Rivastigmine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	5.16e-05	0.00688	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.15e-05	0.00686	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CCT2—osteoporosis	5.1e-05	0.0068	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.02e-05	0.00669	CbGpPWpGaD
Rivastigmine—BCHE—Peptide hormone metabolism—IGF1—osteoporosis	4.97e-05	0.00663	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—TUBA1B—osteoporosis	4.87e-05	0.00648	CbGpPWpGaD
Rivastigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	4.71e-05	0.00627	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.59e-05	0.00612	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.48e-05	0.00597	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—TUBA1B—osteoporosis	4.34e-05	0.00579	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	4.29e-05	0.00571	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.24e-05	0.00565	CbGpPWpGaD
Rivastigmine—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	4.23e-05	0.00563	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	4.23e-05	0.00563	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.01e-05	0.00535	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—ADCY5—osteoporosis	3.97e-05	0.0053	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—RPL24—osteoporosis	3.89e-05	0.00518	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.58e-05	0.00477	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—ADCY5—osteoporosis	3.55e-05	0.00473	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—RPL24—osteoporosis	3.47e-05	0.00462	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—TLN1—osteoporosis	3.42e-05	0.00456	CbGpPWpGaD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	3.42e-05	0.00456	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.41e-05	0.00455	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—IL6—osteoporosis	3.37e-05	0.0045	CbGpPWpGaD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	3.37e-05	0.0045	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	3.37e-05	0.00449	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—REN—osteoporosis	3.29e-05	0.00438	CbGpPWpGaD
Rivastigmine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.14e-05	0.00419	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—FDPS—osteoporosis	3.11e-05	0.00415	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PKM—osteoporosis	3.11e-05	0.00415	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—TLN1—osteoporosis	3.05e-05	0.00406	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—ADCY5—osteoporosis	3.05e-05	0.00406	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.04e-05	0.00406	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GPD2—osteoporosis	2.95e-05	0.00393	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PGLS—osteoporosis	2.95e-05	0.00393	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—REN—osteoporosis	2.93e-05	0.00391	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	2.92e-05	0.00389	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	2.8e-05	0.00373	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—FDPS—osteoporosis	2.78e-05	0.0037	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PKM—osteoporosis	2.78e-05	0.0037	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	2.77e-05	0.00369	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	2.76e-05	0.00368	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—ADCY5—osteoporosis	2.72e-05	0.00362	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ATIC—osteoporosis	2.7e-05	0.0036	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PNP—osteoporosis	2.7e-05	0.0036	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GPD2—osteoporosis	2.63e-05	0.00351	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PGLS—osteoporosis	2.63e-05	0.00351	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.55e-05	0.00339	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ATIC—osteoporosis	2.41e-05	0.00321	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PNP—osteoporosis	2.41e-05	0.00321	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—OXCT1—osteoporosis	2.29e-05	0.00306	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CA2—osteoporosis	2.29e-05	0.00306	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	2.25e-05	0.003	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—MGLL—osteoporosis	2.23e-05	0.00298	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	2.22e-05	0.00296	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.11e-05	0.00281	CbGpPWpGaD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.05e-05	0.00274	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—ACE—osteoporosis	2.05e-05	0.00273	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—OXCT1—osteoporosis	2.05e-05	0.00273	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CA2—osteoporosis	2.05e-05	0.00273	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—MGLL—osteoporosis	1.99e-05	0.00266	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—IDH2—osteoporosis	1.9e-05	0.00253	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.88e-05	0.00251	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—ACE—osteoporosis	1.83e-05	0.00244	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP27A1—osteoporosis	1.79e-05	0.00238	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.75e-05	0.00234	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.75e-05	0.00233	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ACP5—osteoporosis	1.74e-05	0.00232	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.72e-05	0.00229	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—IDH2—osteoporosis	1.7e-05	0.00226	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.67e-05	0.00222	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.63e-05	0.00218	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—TPI1—osteoporosis	1.62e-05	0.00215	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP27A1—osteoporosis	1.59e-05	0.00212	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ACP5—osteoporosis	1.55e-05	0.00207	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.53e-05	0.00204	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—P4HB—osteoporosis	1.52e-05	0.00203	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GAPDH—osteoporosis	1.49e-05	0.00199	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.47e-05	0.00196	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—RAP1A—osteoporosis	1.45e-05	0.00194	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.45e-05	0.00193	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—TPI1—osteoporosis	1.44e-05	0.00192	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—P4HB—osteoporosis	1.36e-05	0.00181	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—POMC—osteoporosis	1.35e-05	0.0018	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GAPDH—osteoporosis	1.33e-05	0.00177	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—RAP1A—osteoporosis	1.3e-05	0.00173	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—FDPS—osteoporosis	1.28e-05	0.0017	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PKM—osteoporosis	1.28e-05	0.0017	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—LEP—osteoporosis	1.27e-05	0.0017	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.27e-05	0.00169	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GPD2—osteoporosis	1.21e-05	0.00161	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PGLS—osteoporosis	1.21e-05	0.00161	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ENO1—osteoporosis	1.17e-05	0.00156	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PSMA2—osteoporosis	1.16e-05	0.00154	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PSMA5—osteoporosis	1.16e-05	0.00154	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—LEP—osteoporosis	1.14e-05	0.00151	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.13e-05	0.00151	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ATIC—osteoporosis	1.11e-05	0.00147	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PNP—osteoporosis	1.11e-05	0.00147	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—POMC—osteoporosis	1.09e-05	0.00146	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—IGF1—osteoporosis	1.05e-05	0.0014	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ENO1—osteoporosis	1.05e-05	0.0014	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PSMA5—osteoporosis	1.03e-05	0.00138	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PSMA2—osteoporosis	1.03e-05	0.00138	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—POMC—osteoporosis	9.76e-06	0.0013	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CA2—osteoporosis	9.41e-06	0.00125	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—OXCT1—osteoporosis	9.41e-06	0.00125	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—IGF1—osteoporosis	9.39e-06	0.00125	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP19A1—osteoporosis	9.39e-06	0.00125	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MGLL—osteoporosis	9.17e-06	0.00122	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—POMC—osteoporosis	8.85e-06	0.00118	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP19A1—osteoporosis	8.37e-06	0.00112	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PKM—osteoporosis	8.34e-06	0.00111	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—FDPS—osteoporosis	8.34e-06	0.00111	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GPD2—osteoporosis	7.91e-06	0.00105	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PGLS—osteoporosis	7.91e-06	0.00105	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—IDH2—osteoporosis	7.79e-06	0.00104	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ADCY5—osteoporosis	7.67e-06	0.00102	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GPX1—osteoporosis	7.64e-06	0.00102	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP27A1—osteoporosis	7.33e-06	0.000977	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PNP—osteoporosis	7.23e-06	0.000964	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ATIC—osteoporosis	7.23e-06	0.000964	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ACP5—osteoporosis	7.13e-06	0.00095	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—MTHFR—osteoporosis	7.05e-06	0.00094	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ADCY5—osteoporosis	6.84e-06	0.000912	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GPX1—osteoporosis	6.82e-06	0.000909	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—TPI1—osteoporosis	6.63e-06	0.000883	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—MTHFR—osteoporosis	6.29e-06	0.000839	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—P4HB—osteoporosis	6.23e-06	0.000831	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CA2—osteoporosis	6.15e-06	0.00082	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—OXCT1—osteoporosis	6.15e-06	0.00082	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GAPDH—osteoporosis	6.12e-06	0.000815	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MGLL—osteoporosis	5.99e-06	0.000799	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—RAP1A—osteoporosis	5.96e-06	0.000794	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—POMC—osteoporosis	5.64e-06	0.000752	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—IDH2—osteoporosis	5.1e-06	0.000679	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—POMC—osteoporosis	5.03e-06	0.000671	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ENO1—osteoporosis	4.82e-06	0.000642	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP27A1—osteoporosis	4.79e-06	0.000639	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PSMA5—osteoporosis	4.75e-06	0.000633	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PSMA2—osteoporosis	4.75e-06	0.000633	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ACP5—osteoporosis	4.66e-06	0.000621	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TPI1—osteoporosis	4.33e-06	0.000578	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—P4HB—osteoporosis	4.07e-06	0.000543	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GAPDH—osteoporosis	4e-06	0.000533	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—RAP1A—osteoporosis	3.89e-06	0.000519	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP19A1—osteoporosis	3.85e-06	0.000513	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ENO1—osteoporosis	3.15e-06	0.00042	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ADCY5—osteoporosis	3.15e-06	0.000419	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GPX1—osteoporosis	3.13e-06	0.000418	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PSMA5—osteoporosis	3.1e-06	0.000414	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PSMA2—osteoporosis	3.1e-06	0.000414	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MTHFR—osteoporosis	2.89e-06	0.000386	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.52e-06	0.000336	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—POMC—osteoporosis	2.31e-06	0.000308	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ADCY5—osteoporosis	2.06e-06	0.000274	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GPX1—osteoporosis	2.05e-06	0.000273	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MTHFR—osteoporosis	1.89e-06	0.000252	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—POMC—osteoporosis	1.51e-06	0.000202	CbGpPWpGaD
